Colleen McCabe, PharmD, BCOP, and Lindsay Mundy, PharmD, BCOP, led an engaging exploration of the benefits and potential pitfalls with the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in an oncology setting in their presentation, GLP-1s in Oncology: Miracle, Misdirection, or Missed Opportunity
Recent studies in MASLD and ALD models demonstrate that supplementation with NAD + precursors (e.g
Telehealth platforms and wellness marketing teams will likely seize on the words removed from Category 2 to imply approval
Endpoints from DXA were absolute appendicular FFM and appendicular FFM normalized to body weight or height
Conclusion: Semaglutide with B12 to counter energy loss for your weight loss journey Semaglutide is a GLP-1 receptor agonist that facilitates weight loss by delaying gastric emptying and reducing appetite, along with a low-calorie diet and physical exercise
They ensure appropriate care tailored to specific needs and health conditions (including ongoing monitoring and support)